Hyman Charles D Vaneck ETF Tr Biotech ETF Transaction History

Hyman Charles D

$1.79 Billion
Q2 2024

A detailed history of Hyman Charles D transactions in Vaneck ETF Tr Biotech ETF stock. As of the latest transaction made, Hyman Charles D holds 1,200 shares of BBH stock, worth $212,112. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,200

Holding current value

$212,112

% of portfolio

0.01%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$151.99 - $172.48 $182,388 - $206,976	1,200 New	1,200 $202,000
Q1 2022 May 09, 2022	SELL	$148.02 - $186.49 $177,624 - $223,788	-1,200 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$173.72 - $201.85 $208,464 - $242,220	1,200 New	1,200 $242,000

Others Institutions Holding BBH

# of Institutions

126

Shares Held

2.7M

Call Options Held

5.7K

Put Options Held

Gfs Advisors, LLC

1.77M
Shares

$313 Million
19.24% of portfolio
Goldman Sachs Group Inc New York, NY

113K
Shares

$19.9 Million
0.0% of portfolio
Miller Investment Management, LP West Conshohocken, PA

104K
Shares

$18.4 Million
2.1% of portfolio
Morgan Stanley New York, NY

72K
Shares

$12.7 Million
0.0% of portfolio
Wells Fargo & Company San Francisco, CA

68.6K
Shares

$12.1 Million
0.0% of portfolio

View Full List

About VANECK ETF TR BIOTECH ETF

Ticker BBH
Sector ETFs
Industry ETFs

More about BBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

News

Stay updated on Hyman Charles D with notifications on news.

Account